(-0.08%) 5 304.25 points
(-0.09%) 40 140 points
(-0.05%) 18 465 points
(-0.07%) $83.11
(-0.62%) $1.752
(0.73%) $2 254.80
(0.74%) $25.10
(0.21%) $923.00
(0.16%) $0.928
(0.33%) $10.88
(0.00%) $0.792
(-0.97%) $91.68
Live Chart Being Loaded With Signals
Stratec SE, together with its subsidiaries, designs and manufactures automation and instrumentation solutions in the fields of in-vitro diagnostics and life sciences in Germany, European Union, and internationally...
Stats | |
---|---|
Today's Volume | 46 140.00 |
Average Volume | 6 924.00 |
Market Cap | 488.67M |
EPS | €0 ( 2024-03-28 ) |
Next earnings date | ( €0 ) 2024-04-26 |
Last Dividend | €0.970 ( 2023-05-18 ) |
Next Dividend | €0 ( N/A ) |
P/E | 40.61 |
ATR14 | €0.189 (0.46%) |
Volume Correlation
Stratec SE Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Stratec SE Correlation - Currency/Commodity
Stratec SE Financials
Annual | 2022 |
Revenue: | €274.63M |
Gross Profit: | €79.49M (28.94 %) |
EPS: | €2.41 |
Q3 | 2023 |
Revenue: | €62.67M |
Gross Profit: | €18.10M (28.87 %) |
EPS: | €0.420 |
Q2 | 2023 |
Revenue: | €64.53M |
Gross Profit: | €12.60M (19.52 %) |
EPS: | €0.0900 |
Q1 | 2023 |
Revenue: | €60.48M |
Gross Profit: | €13.30M (22.00 %) |
EPS: | €0.110 |
Financial Reports:
No articles found.
Stratec SE Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
€0 (N/A) |
€0 (N/A) |
€0 (N/A) |
€0.970 (N/A) |
€0 (N/A) |
€0 (N/A) |
€0 (N/A) |
€0 (N/A) |
€0 (N/A) |
€0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | €0.0267 | 2004-05-17 |
Last Dividend | €0.970 | 2023-05-18 |
Next Dividend | €0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 20 | -- |
Total Paid Out | €11.02 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 1.66 | -- |
Div. Sustainability Score | 5.79 | |
Div.Growth Potential Score | 0.632 | |
Div. Directional Score | 3.21 | -- |
Year | Amount | Yield |
---|
With a moderate Dividend Sustainability Score (DSS), the company may sustain its dividends, but continuous monitoring is advised for any financial shifts. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
ZEG.DE | Ex Dividend Knight | 2023-08-10 | Semi-Annually | 0 | 0.00% | |
HEN3.F | Ex Dividend Knight | 2023-04-25 | Annually | 0 | 0.00% | |
R66.DE | Ex Dividend Knight | 2023-08-17 | Quarterly | 0 | 0.00% | |
COP.DE | Ex Dividend Knight | 2023-05-18 | Annually | 0 | 0.00% | |
JNJ.DE | Ex Dividend Knight | 2023-08-25 | Quarterly | 0 | 0.00% | |
3IT.F | Ex Dividend Junior | 2023-06-29 | Annually | 0 | 0.00% | |
SSUN.F | Ex Dividend Knight | 2023-03-30 | Quarterly | 0 | 0.00% | |
DWS.DE | Ex Dividend Knight | 2023-06-16 | Annually | 0 | 0.00% | |
MBG.DE | Ex Dividend Knight | 2023-05-04 | Annually | 0 | 0.00% | |
AIR.DE | Ex Dividend Knight | 2023-04-25 | Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0472 | 1.500 | 9.06 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0271 | 1.200 | 9.10 | 10.00 | [0 - 0.3] |
returnOnEquityTTM | 0.0533 | 1.500 | -0.519 | -0.779 | [0.1 - 1] |
payoutRatioTTM | 0.980 | -1.000 | 0.197 | -0.197 | [0 - 1] |
currentRatioTTM | 2.28 | 0.800 | 3.62 | 2.89 | [1 - 3] |
quickRatioTTM | 0.762 | 0.800 | -0.223 | -0.178 | [0.8 - 2.5] |
cashRatioTTM | 0.147 | 1.500 | -0.297 | -0.445 | [0.2 - 2] |
debtRatioTTM | 0.330 | -1.500 | 4.50 | -6.76 | [0 - 0.6] |
interestCoverageTTM | 5.99 | 1.000 | 8.89 | 8.89 | [3 - 30] |
operatingCashFlowPerShareTTM | -0.107 | 2.00 | -0.0356 | -0.0711 | [0 - 30] |
freeCashFlowPerShareTTM | -1.823 | 2.00 | -0.911 | -1.823 | [0 - 20] |
debtEquityRatioTTM | 0.647 | -1.500 | 7.41 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.236 | 1.000 | 9.40 | 9.40 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.0740 | 1.000 | -0.520 | -0.520 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | -0.00888 | 1.000 | -1.160 | -1.160 | [0.2 - 2] |
assetTurnoverTTM | 0.575 | 0.800 | 9.50 | 7.60 | [0.5 - 2] |
Total Score | 5.79 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 42.84 | 1.000 | 5.77 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0533 | 2.50 | -0.334 | -0.779 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | -1.823 | 2.00 | -0.608 | -1.823 | [0 - 30] |
dividendYielPercentageTTM | 2.29 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | -0.107 | 2.00 | -0.0356 | -0.0711 | [0 - 30] |
payoutRatioTTM | 0.980 | 1.500 | 0.197 | -0.197 | [0 - 1] |
pegRatioTTM | 0 | 1.500 | -3.33 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | -0.00509 | 1.000 | -2.63 | 0 | [0.1 - 0.5] |
Total Score | 0.632 |
Stratec SE
Stratec SE, together with its subsidiaries, designs and manufactures automation and instrumentation solutions in the fields of in-vitro diagnostics and life sciences in Germany, European Union, and internationally. It operates through three segments: Instrumentation, Diatron, and Smart Consumables. The Instrumentation segment designs and manufactures automated analyzer systems, including service parts and consumables for clinical diagnostics and biotechnology customers. The Diatron segment offers systems, system components, consumables, and tests for the low throughput hematology and clinical chemistry applications. The Smart Consumables segment develops and manufactures smart consumables in the fields of diagnostics, life sciences, and medical technologies. The company was formerly known as STRATEC Biomedical AG and changed its name to Stratec SE in December 2018. Stratec SE was founded in 1979 and is headquartered in Birkenfeld, Germany.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators